> Bavarian Nordic has submitted its smallpox vaccine for marketing approval in Europe, where it will be marketed as Imvanex. Press release

> Medicago and Mitsubishi Tanabe have signed a $33 million deal to develop at least three new vaccines, including a rotavirus vaccine. Press release

> Nuron Biotech has licensed in rights to Akshaya Bio's Chimigen multi-antigen hepatitis B vaccines, as well as an option to license prophylactic and therapeutic products for the hepatitis C virus. Press release

> iBio, a biopharma company that develops plant-based products, has received a patent for its technology to enhance the effectiveness of vaccines. Article